Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Ltd announced the release of 46,900,000 fully paid ordinary shares from escrow, effective 22 August 2025. This action, authorized by the Board, does not alter the company’s issued capital and reflects compliance with ASX Listing Rule 3.10A, potentially impacting shareholder dynamics and market perception.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on developing and providing diagnostic solutions. The company is listed on the Australian Securities Exchange under the ticker COV.
Average Trading Volume: 71,101
Technical Sentiment Signal: Buy
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.